Fiammetta Vanoli

5PUBLICATIONS
19CO-AUTHORS
Panel data analysisPacific Peoples youth and familyNeural engineeringApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 20, 2026
Disease changes and cost analysis of myasthenia gravis: a 10 years retrospective study from a reference center in Italy.

|Jun 19, 2025
Caregiving burden among caregivers of people with myasthenia gravis.

Sarah Dewilde, Nafthali H Tollenaar, Pierre Boulanger

|Mar 25, 2025
Efgartigimod improves non-AChR generalized Myasthenia Gravis: a real world experience.

Carlo Antozzi, Rita Frangiamore, Elena Rinaldi

|Oct 24, 2023
Efgartigimod improves triple-negative myasthenia gravis.

Rita Frangiamore, Elena Rinaldi, Fiammetta Vanoli

|Apr 14, 2023
Reply to: intravenous immunoglobulin (Gamunex® 10%) is licensed for the treatment of severe acute exacerbations of myasthenia gravis.

Fiammetta Vanoli, Renato Mantegazza

Pageof 1

Frequent Collaborators

5 joint publications

Renato Mantegazza

3 joint publications

Rita Frangiamore

3 joint publications

Carlo Antozzi

2 joint publications

Elena Rinaldi